More Debate on the Future of Primary Care
Recently, I posted in Forbes about our need to rethink primary care, to avoid a physician shortage. The debate continues, as seen in this interesting post from Dan Diamond.
(Click here to view comments)
Recently, I posted in Forbes about our need to rethink primary care, to avoid a physician shortage. The debate continues, as seen in this interesting post from Dan Diamond.
(Click here to view comments)
The failure of health care reform does not rest solely at the president’s feet. Instead, we, the general public, are also to blame…(Read the rest and view comments at Scientocracy)
Shutterstock Recently I posted a piece, describing research out of Johns Hopkins, showing that when patients come to ERs – either with no insurance or insurance that is out-of-network – they often face charges that are four, six, or even ten-fold greater than what Medicare would pay for the same services. After the post, I was inundated…
For much of the history of U.S. medical care, hospitals and physicians have existed as separate financial entities. Physicians in the U.S. have typically been self-employed, as solo or group practitioners and not as hospital employees. An internist like me might have admitting privileges to several local hospitals. When we admit patients to one of…
For decades now, policymakers have been trying to slow down the growth of healthcare costs. For much of this time, a large part of that effort was directed at hospital spending. American hospitals are extremely expensive, and take care of patients with the most severe illnesses. So if we’re going to control costs, it seems…
Under the Affordable Care Act, the percent of Americans who lack any health insurance has declined significantly. Put another way – more Americans have health insurance than ever. But having insurance coverage is different than being well covered by insurance. Sometimes a person can enroll in a health insurance plan, and still face the kind of out-of-pocket…
The oncologist had prescribed Xgeva hoping it would strengthen her bones while also delaying the progression of Angela Kahn’s breast cancer. But Kahn (a pseudonym) couldn’t get over the price of the drug. Before the oncologist had a chance to ask how she was feeling, she blurted out that the medication cost “$15,000 a shot.”…